Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

11 terminated/withdrawn out of 220 trials

Success Rate

93.4%

+6.9% vs industry average

Late-Stage Pipeline

11%

25 trials in Phase 3/4

Results Transparency

3%

5 of 156 completed trials have results

Key Signals

7 recruiting5 with results9 terminated

Enrollment Performance

Analytics

N/A
124(72.1%)
Phase 4
21(12.2%)
Phase 2
14(8.1%)
Phase 1
5(2.9%)
Early Phase 1
4(2.3%)
Phase 3
4(2.3%)
172Total
N/A(124)
Phase 4(21)
Phase 2(14)
Phase 1(5)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (220)

Showing 20 of 220 trials
NCT05613439Completed

The Fast-track Centre for Hip and Knee Replacement Database

Role: collaborator

NCT05192031Not ApplicableCompleted

Implementation of Smoking Cessation Support During Lung Cancer Workup

Role: collaborator

NCT05084846Completed

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection

Role: lead

NCT06845033Not ApplicableActive Not Recruiting

Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity

Role: lead

NCT07506369Not ApplicableRecruiting

Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans

Role: lead

NCT07432802Not ApplicableNot Yet Recruiting

Sublobar Wedge Resection or Stereotactic Radiotherapy Treatment of High-risk Patients With Early-stage Lung Cancer

Role: collaborator

NCT07424690Not ApplicableNot Yet Recruiting

Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation

Role: collaborator

NCT06787001Completed

Understanding How Gut and Brain Barriers Are Linked to Inflammation in Obesity

Role: lead

NCT05657054Not ApplicableActive Not Recruiting

Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement

Role: collaborator

NCT07171723Phase 1Recruiting

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Role: lead

NCT06895408Not ApplicableCompleted

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

Role: lead

NCT06881459Not ApplicableCompleted

The Effect of Oxytocin on the Alpha Cell Response to Hypoglycaemia in Patients With Type 1 Diabetes

Role: lead

NCT06934473Not ApplicableRecruiting

Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals

Role: lead

NCT06254365Not ApplicableActive Not Recruiting

Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT

Role: lead

NCT06548009Completed

Serum Metabolics-based Method for Diagnosing Bile Acid Diarrhoea

Role: lead

NCT06435494Not ApplicableEnrolling By Invitation

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions

Role: lead

NCT05953064Not ApplicableActive Not Recruiting

Effects of DHA-NAT on Postprandial Lipidaemia in Healthy Male Subjects

Role: lead

NCT06189001Not ApplicableCompleted

The Role of Oxytocin-receptor Signalling in Physiological Regulation of Eating Behaviour in Individuals with Obesity

Role: lead

NCT06208904Not ApplicableEnrolling By Invitation

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

Role: lead

NCT06831799Completed

ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19

Role: collaborator